Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
$3.01
-2.0%
$4.12
$2.23
$6.89
$513.87M0.92.51 million shs1.56 million shs
Chubb Limited stock logo
CB
Chubb
$252.05
+1.4%
$251.90
$183.71
$260.58
$102.35B0.631.73 million shs756,406 shs
The Cigna Group stock logo
CI
The Cigna Group
$342.41
+0.3%
$350.77
$240.50
$365.71
$97.27B0.571.59 million shs1.32 million shs
Oshkosh Co. stock logo
OSK
Oshkosh
$116.43
+1.8%
$118.21
$72.09
$127.98
$7.48B1.3491,655 shs324,609 shs
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
$65.02
+1.0%
$64.89
$55.12
$71.18
$57.08B1.647.48 million shs8.27 million shs
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$43.41
+2.1%
$43.96
$37.78
$90.45
$2.84B0.17867,860 shs762,813 shs
Tesla, Inc. stock logo
TSLA
Tesla
$184.76
+2.0%
$173.56
$138.80
$299.29
$577.85B2.41109.59 million shs84.17 million shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
-1.95%+5.99%-23.99%-26.76%-54.39%
Chubb Limited stock logo
CB
Chubb
+1.41%+1.14%-0.34%+1.78%+26.70%
The Cigna Group stock logo
CI
The Cigna Group
+0.27%-3.96%-5.53%+4.53%+31.32%
Oshkosh Co. stock logo
OSK
Oshkosh
+1.77%-1.23%-8.43%+4.05%+53.26%
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
+0.98%-4.70%-6.11%+12.94%+7.13%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
+2.14%+10.29%+1.66%-36.92%-51.01%
Tesla, Inc. stock logo
TSLA
Tesla
+1.97%-4.79%+12.04%-0.18%+8.64%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
1.2928 of 5 stars
3.40.00.00.01.03.30.6
Chubb Limited stock logo
CB
Chubb
4.6407 of 5 stars
2.33.04.22.02.92.52.5
The Cigna Group stock logo
CI
The Cigna Group
4.7871 of 5 stars
1.55.02.54.23.12.53.1
Oshkosh Co. stock logo
OSK
Oshkosh
4.5725 of 5 stars
2.35.02.51.24.02.51.9
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
4.2582 of 5 stars
3.31.02.50.02.51.73.1
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
4.8684 of 5 stars
4.03.00.03.82.33.32.5
Tesla, Inc. stock logo
TSLA
Tesla
4.4821 of 5 stars
2.04.00.03.52.44.22.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
2.71
Moderate Buy$13.50348.50% Upside
Chubb Limited stock logo
CB
Chubb
2.56
Moderate Buy$266.895.89% Upside
The Cigna Group stock logo
CI
The Cigna Group
2.92
Moderate Buy$366.146.93% Upside
Oshkosh Co. stock logo
OSK
Oshkosh
2.63
Moderate Buy$123.506.07% Upside
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
2.50
Moderate Buy$71.9410.64% Upside
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
2.00
Hold$61.6041.90% Upside
Tesla, Inc. stock logo
TSLA
Tesla
2.06
Hold$185.900.62% Upside

Current Analyst Ratings

Latest TSLA, CB, CI, OSK, OXY, QDEL, and ALLO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/3/2024
The Cigna Group stock logo
CI
The Cigna Group
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$384.00 ➝ $400.00
5/3/2024
The Cigna Group stock logo
CI
The Cigna Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$370.00 ➝ $400.00
5/2/2024
Tesla, Inc. stock logo
TSLA
Tesla
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$230.00
4/29/2024
Tesla, Inc. stock logo
TSLA
Tesla
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$155.00 ➝ $145.00
4/29/2024
Tesla, Inc. stock logo
TSLA
Tesla
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$275.00
4/26/2024
Oshkosh Co. stock logo
OSK
Oshkosh
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $140.00
4/26/2024
Oshkosh Co. stock logo
OSK
Oshkosh
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$121.00 ➝ $132.00
4/26/2024
Oshkosh Co. stock logo
OSK
Oshkosh
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$140.00 ➝ $158.00
4/25/2024
Chubb Limited stock logo
CB
Chubb
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$295.00 ➝ $285.00
4/25/2024
Tesla, Inc. stock logo
TSLA
Tesla
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$123.00 ➝ $136.00
4/24/2024
Chubb Limited stock logo
CB
Chubb
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$280.00
(Data available from 5/7/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
$90K5,709.64N/AN/A$3.04 per share0.99
Chubb Limited stock logo
CB
Chubb
$49.74B2.06$23.60 per share10.68$156.11 per share1.61
The Cigna Group stock logo
CI
The Cigna Group
$195.27B0.50$35.93 per share9.53$158.03 per share2.17
Oshkosh Co. stock logo
OSK
Oshkosh
$9.66B0.79$12.71 per share9.16$56.64 per share2.06
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
$28.92B1.99$11.97 per share5.43$25.06 per share2.59
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$3.00B0.97$11.25 per share3.86$74.92 per share0.58
Tesla, Inc. stock logo
TSLA
Tesla
$96.77B6.09$4.40 per share42.00$19.90 per share9.28

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
-$327.27M-$2.09N/AN/AN/A-202,366.25%-53.76%-43.24%5/8/2024 (Estimated)
Chubb Limited stock logo
CB
Chubb
$9.03B$22.5311.1910.901.1717.99%16.29%4.35%7/23/2024 (Estimated)
The Cigna Group stock logo
CI
The Cigna Group
$5.16B$12.1828.1110.701.041.76%17.24%5.09%8/1/2024 (Estimated)
Oshkosh Co. stock logo
OSK
Oshkosh
$598M$10.4511.149.881.206.93%20.39%8.31%8/6/2024 (Estimated)
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
$4.70B$3.9116.6312.98N/A16.24%20.63%6.00%5/7/2024 (Confirmed)
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
-$10.10M-$0.16N/A11.55N/A-0.34%5.54%3.21%5/8/2024 (Confirmed)
Tesla, Inc. stock logo
TSLA
Tesla
$15.00B$3.9247.1372.454.7414.37%13.18%7.72%7/17/2024 (Estimated)

Latest TSLA, CB, CI, OSK, OXY, QDEL, and ALLO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$0.54N/A-$0.54N/AN/AN/A  
5/7/2024N/A
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
$0.62N/A-$0.62N/AN/AN/A  
5/2/2024Q1 2024
The Cigna Group stock logo
CI
The Cigna Group
$6.17$6.47+$0.30$13.91$56.59 billion$57.25 billion    
4/25/2024Q1 2024
Oshkosh Co. stock logo
OSK
Oshkosh
$2.26$2.89+$0.63$3.07$2.49 billion$2.54 billion    
4/23/2024Q1 2024
Chubb Limited stock logo
CB
Chubb
$5.29$5.41+$0.12$5.59$11.75 billion$12.22 billion      
3/14/2024Q4 2023
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
-$0.47-$0.43+$0.04-$0.35$0.05 million$0.02 million
2/15/2024Q4 23
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
$0.74$0.74N/A$0.40$6.93 billion$7.53 billion      
2/13/2024Q4 2023
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$2.01$1.17-$0.84$2.24$796.91 million$742.60 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
N/AN/AN/AN/AN/A
Chubb Limited stock logo
CB
Chubb
$3.441.36%+3.34%15.27%30 Years
The Cigna Group stock logo
CI
The Cigna Group
$5.601.64%+397.32%45.98%4 Years
Oshkosh Co. stock logo
OSK
Oshkosh
$1.841.58%+10.06%17.61%2 Years
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
$0.881.35%-4.24%22.51%3 Years
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
N/AN/AN/AN/AN/A
Tesla, Inc. stock logo
TSLA
Tesla
N/AN/AN/AN/AN/A

Latest TSLA, CB, CI, OSK, OXY, QDEL, and ALLO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2024
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
quarterly$0.221.4%6/7/20246/10/20247/15/2024
4/24/2024
The Cigna Group stock logo
CI
The Cigna Group
quarterly$1.401.59%6/4/20246/4/20246/20/2024
4/25/2024
Oshkosh Co. stock logo
OSK
Oshkosh
Quarterly$0.461.55%5/10/20245/13/20245/28/2024
2/8/2024
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
quarterly$0.221.52%3/7/20243/8/20244/15/2024
2/22/2024
Chubb Limited stock logo
CB
Chubb
quarterly$0.861.37%3/14/20243/15/20244/5/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
N/A
12.38
12.38
Chubb Limited stock logo
CB
Chubb
0.21
0.29
0.29
The Cigna Group stock logo
CI
The Cigna Group
0.75
0.71
0.71
Oshkosh Co. stock logo
OSK
Oshkosh
0.16
1.43
0.76
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
0.84
0.92
0.69
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
0.45
1.57
0.88
Tesla, Inc. stock logo
TSLA
Tesla
0.04
1.72
1.17

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
83.63%
Chubb Limited stock logo
CB
Chubb
83.81%
The Cigna Group stock logo
CI
The Cigna Group
86.99%
Oshkosh Co. stock logo
OSK
Oshkosh
92.36%
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
88.70%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
99.00%
Tesla, Inc. stock logo
TSLA
Tesla
66.20%

Insider Ownership

CompanyInsider Ownership
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
24.30%
Chubb Limited stock logo
CB
Chubb
0.86%
The Cigna Group stock logo
CI
The Cigna Group
0.70%
Oshkosh Co. stock logo
OSK
Oshkosh
0.58%
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
0.48%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
1.00%
Tesla, Inc. stock logo
TSLA
Tesla
20.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
232170.72 million129.24 millionOptionable
Chubb Limited stock logo
CB
Chubb
40,000406.06 million402.57 millionOptionable
The Cigna Group stock logo
CI
The Cigna Group
72,500284.07 million282.09 millionOptionable
Oshkosh Co. stock logo
OSK
Oshkosh
17,30065.40 million65.02 millionOptionable
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
12,570886.47 million882.21 millionOptionable
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
7,10066.88 million66.21 millionOptionable
Tesla, Inc. stock logo
TSLA
Tesla
140,4733.19 billion2.52 billionOptionable

TSLA, CB, CI, OSK, OXY, QDEL, and ALLO Headlines

SourceHeadline
Tesla Stock Falls. Lucids Results Are Another Example of Slowing EV Demand.Tesla Stock Falls. Lucid's Results Are Another Example of Slowing EV Demand.
barrons.com - May 7 at 4:59 AM
Teslas China-made EV sales fall 18% y/y in AprilTesla's China-made EV sales fall 18% y/y in April
reuters.com - May 7 at 4:50 AM
Exclusive-Chinas Nio turns to rival BYD to power new EV brand, sources sayExclusive-China's Nio turns to rival BYD to power new EV brand, sources say
ca.finance.yahoo.com - May 7 at 1:26 AM
Tesla, Inc. (NASDAQ:TSLA) Shares Sold by Empirical Financial Services LLC d.b.a. Empirical Wealth ManagementTesla, Inc. (NASDAQ:TSLA) Shares Sold by Empirical Financial Services LLC d.b.a. Empirical Wealth Management
marketbeat.com - May 6 at 11:46 PM
Tesla Trims Software and Service Teams in Broader Workforce ReductionTesla Trims Software and Service Teams in Broader Workforce Reduction
quiverquant.com - May 6 at 11:32 PM
Tesla (TSLA) launches another round of layoffsTesla (TSLA) launches another round of layoffs
electrek.co - May 6 at 8:26 PM
Elon Musk Wants Buffett to Buy Tesla Stock: ‘It’s an Obvious Move.’Elon Musk Wants Buffett to Buy Tesla Stock: ‘It’s an Obvious Move.’
finance.yahoo.com - May 6 at 8:26 PM
Wayve raises $1B to take its Tesla-like technology for self-driving to many carmakersWayve raises $1B to take its Tesla-like technology for self-driving to many carmakers
techcrunch.com - May 6 at 8:26 PM
Tesla Cutting Jobs Across Departments as Part of RestructuringTesla Cutting Jobs Across Departments as Part of Restructuring
pymnts.com - May 6 at 7:37 PM
Tesla (NASDAQ:TSLA) Shares Up 0.8%Tesla (NASDAQ:TSLA) Shares Up 0.8%
marketbeat.com - May 6 at 7:33 PM
Wayve raises $1 billion to take its Tesla-like technology for self-driving to many carmakersWayve raises $1 billion to take its Tesla-like technology for self-driving to many carmakers
techcrunch.com - May 6 at 7:00 PM
TSLA Stock Alert: A Third Round of Tesla Layoffs Just Hit StaffTSLA Stock Alert: A Third Round of Tesla Layoffs Just Hit Staff
investorplace.com - May 6 at 5:12 PM
Here’s Why Tesla (NASDAQ:TSLA) Sued Tesla Power IndiaHere’s Why Tesla (NASDAQ:TSLA) Sued Tesla Power India
msn.com - May 6 at 3:26 PM
Since Tesla recalled its vehicles in 2023, there have been 20 accidents and investigators are asking whySince Tesla recalled its vehicles in 2023, there have been 20 accidents and investigators are asking why
techxplore.com - May 6 at 3:21 PM
Elon Musk Says Tesla Is Discussing Licensing Self-Driving Technology With "One Major Automaker." Heres Who I Think It Is and Why I See Tesla Stock as the Better Buy.Elon Musk Says Tesla Is Discussing Licensing Self-Driving Technology With "One Major Automaker." Here's Who I Think It Is and Why I See Tesla Stock as the Better Buy.
fool.com - May 6 at 2:07 PM
Cathie Woods Latest Buys: 3 Stocks the ARK Invest CEO Cant Get Enough OfCathie Wood's Latest Buys: 3 Stocks the ARK Invest CEO Can't Get Enough Of
investorplace.com - May 6 at 1:04 PM
Tesla Lays Off More Employees Over Weekend: ReportTesla Lays Off More Employees Over Weekend: Report
benzinga.com - May 6 at 12:38 PM
Tesla Has a New Model. It Should Boost Sales.Tesla Has a New Model. It Should Boost Sales.
barrons.com - May 6 at 12:38 PM
Tesla reportedly laying off staff in software, service teams just 1 month after mass firingsTesla reportedly laying off staff in software, service teams just 1 month after mass firings
nypost.com - May 6 at 12:35 PM
Tesla Stock: Weve Got a Big ProblemTesla Stock: We've Got a Big Problem
fool.com - May 6 at 12:10 PM
Tesla lays off more staff in software, service teams, Electrek reportsTesla lays off more staff in software, service teams, Electrek reports
reuters.com - May 6 at 11:41 AM
Elon Musk says Warren Buffett should buy Tesla stock. Heres why he probably never will.Elon Musk says Warren Buffett should buy Tesla stock. Here's why he probably never will.
businessinsider.com - May 6 at 11:29 AM
Detached From Reality: Welcome To The Tesla vs. $TSLA Showdown'Detached From Reality': Welcome To The Tesla vs. $TSLA Showdown
msn.com - May 6 at 10:25 AM
Elon Musk Says Warren Buffett Should Buy Tesla Stock After These CommentsElon Musk Says Warren Buffett Should Buy Tesla Stock After These Comments
finance.yahoo.com - May 6 at 10:25 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Allogene Therapeutics logo

Allogene Therapeutics

NASDAQ:ALLO
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma; and is in Phase 1b clinical trial for the treatment of chronic lymphocytic leukemia. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase 1 clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; ALLO-316, an allogeneic CAR T cell product candidate that is in Phase 1 clinical trial for the treatment of advanced or metastatic RCC; ALLO-329 for the treatment of certain autoimmune diseases; DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors; and Claudin 18.2 for the treatment of gastric and pancreatic cancer. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California.
Chubb logo

Chubb

NYSE:CB
Chubb Limited provides insurance and reinsurance products worldwide. The company's North America Commercial P&C Insurance segment offers commercial property, casualty, workers' compensation, package policies, risk management, financial lines, marine, construction, environmental, medical risk, cyber risk, surety, and casualty; and group accident and health insurance to large, middle market, and small commercial businesses. Its North America Personal P&C Insurance segment provides affluent and high net worth individuals and families with homeowners, automobile and collector cars, valuable articles, personal and excess liability, travel insurance, and recreational marine insurance and services. The company's North America Agricultural Insurance segment offers multiple peril crop and crop-hail insurance; and coverage for farm, ranch, and specialty property and casualty, and commercial agriculture products. Its Overseas General Insurance segment provides coverage for traditional commercial property and casualty; specialty categories, such as financial lines, marine, energy, aviation, political risk, and construction; and group accident and health, and traditional and specialty personal lines for corporations, middle markets, and small customers through retail brokers, agents, and other channels. The company's Global Reinsurance segment offers traditional and specialty reinsurance under the Chubb Tempest Re brand to property and casualty companies. Its Life Insurance segment provides protection and savings products comprising whole life, endowment plans, individual and life, group term life, health protection, personal accident, credit life, universal life, group employee benefits, and unit linked contracts. It markets its products primarily through insurance and reinsurance brokers. The company was formerly known as ACE Limited and changed its name to Chubb Limited in January 2016. Chubb Limited was incorporated in 1985 and is headquartered in Zurich, Switzerland.
The Cigna Group logo

The Cigna Group

NYSE:CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Oshkosh logo

Oshkosh

NYSE:OSK
Oshkosh Corporation provides purpose-built vehicles and equipment worldwide. The company operates through three segments: Access, Defense, and Vocational segment. Its Access Equipment segment design and manufacture aerial work platform and telehandlers for use in construction, industrial, and maintenance applications; offers financing and leasing solutions including rental fleet loans, leases, and floor plan and retail financing; and towing and recovery equipment, which includes carriers, wreckers, and rotators, as well as provides equipment installation and sale of chassis and service parts. The Defense segment engages in the manufacture and sale of heavy, medium, and light tactical wheeled vehicles and related services for department of defense. Its Vocational segment offers custom and commercial firefighting equipment, fire apparatus, and emergency vehicles, including pumpers, aerial platform, ladder and tiller trucks, and tankers; light, medium, and heavy-duty rescue vehicles; and wildland rough terrain response, bomb squad, hazardous materials control vehicles, mobile command and control centers, and other emergency response vehicles. Additionally, this segment produces and sells custom and commercial firefighting vehicles, as well as command vehicles, ARFF vehicles; design and manufacture refuse collection vehicles for waste services industry; front discharge concrete mixers for the concrete ready-mix industry; and field service vehicles and truck-mounted cranes for construction, equipment dealer, building supply, utility, tire service, railroad, and mining industries. Further, the company provides its products through direct sales representatives, dealers, and distributors. Oshkosh Corporation was formerly known as Oshkosh Truck Corporation. The company was founded in 1917 and is headquartered in Oshkosh, Wisconsin.
Occidental Petroleum logo

Occidental Petroleum

NYSE:OXY
Occidental Petroleum Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of oil and gas properties in the United States, the Middle East, and North Africa. It operates through three segments: Oil and Gas, Chemical, and Midstream and Marketing. The company's Oil and Gas segment explores for, develops, and produces oil and condensate, natural gas liquids (NGLs), and natural gas. Its Chemical segment manufactures and markets basic chemicals, including chlorine, caustic soda, chlorinated organics, potassium chemicals, ethylene dichloride, chlorinated isocyanurates, sodium silicates, and calcium chloride; and vinyls comprising vinyl chloride monomer, polyvinyl chloride, and ethylene. The Midstream and Marketing segment gathers, processes, transports, stores, purchases, and markets oil, condensate, NGLs, natural gas, carbon dioxide, and power. This segment also invests in entities. Occidental Petroleum Corporation was founded in 1920 and is headquartered in Houston, Texas.
QuidelOrtho logo

QuidelOrtho

NASDAQ:QDEL
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
Tesla logo

Tesla

NASDAQ:TSLA
Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.